MEDEXPRIM
815 La Pyreneenne – Labege – 31670
VAT: FR95814667267
nan
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, MEDEXPRIM has received € 677,500.0 for its participation in a total of 1 project(s) with a total cost of € 8,784,038.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-09-01 | 952172 | CHAIMELEON | lung cancer · colorectal cancer | 2024-08-31 | participant | € 677,500.0 | € 8,784,038 | 1 | 18 | CORDIS ↪ |
Within the Horizon Europe (2021-2027) framework, MEDEXPRIM has received € 936,500.0 for its participation in a total of 1 project(s) with a total cost of € 9,365,096.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-01 | 101136299 | ARTEMIS | infectious diseases · hepatology · cardiology | 2027-12-31 | participant | € 936,500.0 | € 9,365,096 | 1 | 21 | CORDIS ↪ |
MEDEXPRIM did not participate in FP7 (2007-2013).